Cargando…
Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance
Osteosarcoma is the most common primary tumor of bone occurring in children and adolescents. The histological response to chemotherapy represents a key clinical factor related to survival. We previously showed that statins exhibit antitumor effects in vitro, inducing apoptotic cell death, reducing c...
Autores principales: | Habel, N, Hamidouche, Z, Girault, I, Patiño-García, A, Lecanda, F, Marie, P J, Fromigué, O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920934/ https://www.ncbi.nlm.nih.gov/pubmed/24157868 http://dx.doi.org/10.1038/cddis.2013.405 |
Ejemplares similares
-
CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process
por: Habel, Nadia, et al.
Publicado: (2019) -
Synergistic Anti-Tumor Effect of Simvastatin Combined to Chemotherapy in Osteosarcoma
por: Mangelinck, Adèle, et al.
Publicado: (2021) -
FHL2 Silencing Reduces Wnt Signaling and Osteosarcoma Tumorigenesis In Vitro and In Vivo
por: Brun, Julia, et al.
Publicado: (2013) -
P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma.
por: Shnyder, S. D., et al.
Publicado: (1998) -
Crystals of cadmium, zinc metallothionein.
por: Melis, K A, et al.
Publicado: (1984)